Everything below concerns sirtuins. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-03-14. Where a claim depends on a specific study, the study is described rather than over-claimed.
Cells produce NAD+ through several biosynthetic routes. The salvage pathway recycles nicotinamide, while the Preiss-Handler pathway uses nicotinic acid, and a de novo route can start from tryptophan in some organisms. In mammals, the salvage pathway is generally considered the main source under ordinary conditions. Tissue concentrations vary widely by cell type and compartment, and measured declines with age have been reported in some studies. Whether such changes drive aging or mainly accompany it remains an open question.
Nicotinamide adenine dinucleotide, commonly abbreviated NAD+, is a coenzyme present in all living cells. The molecule consists of two nucleotides linked by phosphate groups, with adenine and a nicotinamide ring as its principal features. In its oxidized form, the nicotinamide ring can accept a hydride ion, becoming NADH. This reversible conversion places NAD+ at the center of many electron-transfer reactions. Its role as a redox carrier is well established across bacteria, plants, fungi, and animals.
Beyond redox chemistry, NAD+ acts as a substrate for several enzyme families. ADP-ribosyltransferases, sirtuins, and CD38 ectoenzymes cleave the molecule into nicotinamide and ADP-ribose or related products. These reactions connect NAD+ availability to processes such as DNA repair, chromatin modification, and calcium signaling. Because the coenzyme is used in both electron transfer and signaling, cells maintain separate pools in compartments including the cytosol, mitochondria, and nucleus. The relative sizes and regulation of those pools remain active areas of study.
Biosynthesis of NAD+ starts from nicotinamide, nicotinic acid, or nicotinamide riboside through salvage pathways. A rate-limiting enzyme, nicotinamide phosphoribosyltransferase, converts nicotinamide to nicotinamide mononucleotide. Further coupling with ATP yields NAD+. In mammals, the liver and muscle can synthesize NAD+ from dietary precursors, but tissue levels vary widely. Researchers study these pathways to understand age-related changes, metabolic disorders, and neurodegeneration. Direct causal links between NAD+ decline and disease remain an active area of investigation.
NAD+ is a dinucleotide composed of adenine, ribose, and nicotinamide groups joined by phosphate linkages. It serves as a coenzyme in oxidoreductase reactions, cycling between oxidized NAD+ and reduced NADH. The molecule is water-soluble and occurs in all living cells. Its nicotinamide ring accepts hydride ions during catabolic reactions, linking substrate oxidation to electron transport. This redox couple supports ATP production and helps maintain cytosolic and mitochondrial redox balance in many cell types.
Beyond redox catalysis, NAD+ is a substrate for enzymes that transfer ADP-ribose or remove acetyl groups from proteins. Sirtuins and poly(ADP-ribose) polymerases consume NAD+ and release nicotinamide as a byproduct. These reactions connect cellular energy status to gene regulation, DNA repair, and stress responses. Because NAD+ is used rather than merely recycled in such signaling, its concentration reflects both biosynthesis and consumption. The balance between salvage and de novo synthesis pathways determines available pools in different tissues.
| Property | Value | Notes |
|---|---|---|
| Chemical formula | C21H27N7O14P2 | Oxidized free acid form; charge depends on pH. |
| Molar mass | 663.43 g/mol | Calculated for the free acid. |
| CAS Registry Number | 53-84-9 | For the anhydrous free acid; salts have different identifiers. |
| Appearance | White to off-white powder | Solid material; hygroscopic. |
| Solubility | Water-soluble | Dissolves in aqueous buffers; solubility varies with pH and salt. |
Quality control for NAD+ relies on identity, purity, and functional tests. A certificate of analysis may report high-performance liquid chromatography purity, ultraviolet spectrum, water content, and residual solvents. Because NAD+ is hygroscopic, gravimetric values can shift as material absorbs water, so purity should be interpreted alongside storage history. Mass spectrometry confirms molecular identity, while enzymatic assays show whether the material supports dehydrogenase activity. Commercial material is available as the free acid and as salts, and the counterion affects molecular weight, solubility, and how concentrations are calculated.
Laboratory measurement of NAD+ usually begins with rapid sample quenching because the molecule can change form after collection. Enzymatic cycling assays amplify signal through coupled reactions and are suited to small samples. High-performance liquid chromatography with ultraviolet detection separates NAD+ from related nucleotides. Liquid chromatography-mass spectrometry offers higher specificity and can distinguish NAD+ from close analogs. Each method has trade-offs in sensitivity, throughput, and equipment needs, so reported values depend heavily on extraction and detection choices.
Stability of NAD+ depends on form, temperature, pH, and water content. The solid is generally more stable than solutions, and it should be kept dry and cold. In solution, hydrolysis can cleave the dinucleotide, especially under alkaline conditions or at elevated temperature. Light exposure may also contribute to degradation. Buffers, chelating agents, and sterile handling can reduce losses, but no single condition preserves all preparations indefinitely. Researchers often prepare working solutions shortly before use and verify activity or purity after storage.
NAD+ also serves as a substrate for enzymes that cleave it, including sirtuins, PARPs, and CD38. These enzymes consume NAD+ and release nicotinamide and ADP-ribose or related products. The dual roles as redox cofactor and signaling substrate connect NAD+ to DNA repair, circadian regulation, and calcium signaling. Cellular NAD+ concentrations vary by tissue, time of day, and stress exposure. How these consumption pathways interact with redox balance remains an active area of research.
NAD+ is a dinucleotide composed of two nucleotides joined by a pyrophosphate linkage. One nucleotide contains adenine, and the other contains nicotinamide. The oxidized form carries a positive charge on the nicotinamide ring and is abbreviated NAD+. It functions as a cofactor in hydride-transfer reactions, accepting electrons in catabolic pathways. In cells, it interconverts with reduced NADH, forming a redox couple central to energy metabolism. The molecule is water-soluble and does not cross cell membranes freely without specific transport or precursor pathways.
The nicotinamide ring undergoes reversible reduction at the para position, converting NAD+ to NADH. This reaction transfers a hydride equivalent, not a free hydrogen atom or electron alone. Because the redox pair has a defined reduction potential, it links oxidation of fuels to respiratory chain activity. Many dehydrogenases use NAD+ as a co-substrate and produce NADH. The ratio of NAD+ to NADH reflects metabolic state and influences flux through several pathways.
In humans, NAD+ can be synthesized from nicotinic acid, nicotinamide, nicotinamide riboside, and tryptophan through overlapping pathways. The salvage pathway recycles nicotinamide back to NAD+ and is often considered a major route in many tissues. Dietary precursors and intracellular recycling both contribute to the pool, but the quantitative importance of each source remains an active research question. NAD+ levels are not uniform across organs or cell compartments. Measurements in blood do not necessarily reflect concentrations inside tissues.
NAD+ is a dinucleotide composed of nicotinamide, ribose, and adenine linked by phosphate groups. Its full name is nicotinamide adenine dinucleotide, with "+" denoting the oxidized form. The molecule acts as a coenzyme in redox reactions, cycling between NAD+ and NADH. In cells, it participates in electron transfer during glycolysis, the citric acid cycle, and oxidative phosphorylation. It is distinct from NADP+, which carries an additional phosphate group and supports different biosynthetic reactions.
Beyond redox chemistry, NAD+ serves as a substrate for enzymes that transfer ADP-ribose or remove acetyl groups. Sirtuins, PARPs, and CD38-family enzymes consume NAD+ and produce nicotinamide and ADP-ribose-related products. These reactions link NAD+ availability to DNA repair, chromatin modification, and cellular signaling. Because the molecule is central to energy metabolism and regulation, changes in its concentration are studied in aging, immunity, and metabolic research. The balance between synthesis and consumption varies by tissue, developmental stage, and physiological state.
The molecule was first described in the early twentieth century as a factor that promoted fermentation in yeast extracts. Later work linked it to hydrogen transfer and to the oxidation of nutrients in living tissues. Its structure was resolved as a dinucleotide, which explained why it could accept and donate electrons at specific enzyme sites. Today, NAD+ is recognized as a central substrate and signaling precursor, not merely a metabolic cofactor. Whether all observed NAD+ changes reflect causal signaling remains an open question.
Related compounds include NADH, the reduced form, and NADP+, which carries an additional phosphate group. NADP+ and NADPH often serve in biosynthetic and antioxidant reactions, while NAD+ and NADH are more associated with energy-yielding catabolism. Nicotinamide, nicotinic acid, and nicotinamide riboside are precursors that can enter salvage pathways. The exact contribution of dietary precursors to tissue NAD+ pools is an area of active investigation. Some studies measure labeled precursors to trace those routes.
NAD+ is the oxidized form of nicotinamide adenine dinucleotide, a coenzyme built from two nucleotides joined by a phosphate linkage. One nucleotide carries adenine, and the other carries nicotinamide; the plus sign denotes a formal positive charge on the nicotinamide ring, not a free proton. In cells, NAD+ and its reduced partner NADH form a reversible redox pair. That pair participates in electron transfer reactions throughout metabolism. The abbreviation NAD+ is common in biochemistry, while NAD(H) sometimes denotes the combined pool.
===== Sliding-rebinding model ===== The sliding-rebinding model differs from the allosteric model in that the allosteric model posits that only one binding site exists and can be altered, but the sliding-rebinding model states that multiple binding sites exist and aren't changed by EGF extension. Rather, in the bent conformation which is favored at low applied forces, the applied force is perpendicular to the line of possible binding sites. Thus, when the association between ligand and lectin domain is interrupted, the bond quickly dissociates. At larger applied forces, however, the protein is extended and the line of possible binding sites is aligned with the applied force, allowing the ligand to quickly re-associate with a new binding site after the initial interaction is disrupted. With multiple binding sites, and even the ability to re-associate with the original binding site, the rate of ligand dissociation would be decreased as is typical of catch bonds.
Electrodes and Structural Transformations: During charge and discharge cycles, the materials in the anodes and cathodes undergo local structural transformations. These changes can be monitored using NMR by analyzing the signal's line shape, line intensity, and chemical shift. These transformations are often not captured by X-ray diffraction techniques (providing long-range information), making NMR indispensable for understanding the underlying mechanisms of energy storage. Metal Dendrite Formation: One of the challenges in lithium and sodium-based batteries is the formation of metal dendrites, which can lead to short circuits and catastrophic battery failure. In Situ NMR allows researchers to observe the formation of lithium or sodium dendrites in real time during battery cycling. Varying the cycling rates can also quantify the effect on dendrite formation, aiding in the development of strategies to suppress dendrite growth and reduce the risk of short circuits. Solid Electrolytes and Interfaces: Solid electrolytes, a key focus of next-generation battery research, often suffer from limited ion diffusion rates. NMR techniques can measure diffusivity in solid electrolytes, helping researchers understand how to enhance ion conductivity. Furthermore, NMR is used to study the Solid Electrolyte Interface (SEI), a layer that forms on the electrode surface and thus influences battery stability. Solid-state NMR (ssNMR) is particularly valuable for characterizing the composition and ion dynamics within the SEI layer due to its nondestructive testing capabilities.
=== Testing === The American Heart Association recommends testing cholesterol every four to six years for people aged 20 years or older. A separate set of American Heart Association guidelines issued in 2013 indicates that people taking statin medications should have their cholesterol tested 4–12 weeks after their first dose and then every 3–12 months thereafter. For men ages 45 to 65 and women ages 55 to 65, a cholesterol test should be performed every one to two years, and an annual test should be performed for seniors over the age of 65. After 12 hours of fasting, a blood sample is taken by a healthcare professional from an arm vein to measure a lipid profile for a) total cholesterol, b) HDL cholesterol, c) LDL cholesterol, and d) triglycerides. Results may be expressed as "calculated", indicating a calculation of total cholesterol, HDL, and triglycerides. Cholesterol is tested to determine for "normal" or "desirable" levels if a person has a total cholesterol of 5.2 mmol/L or less (200 mg/dL), an HDL value of more than 1 mmol/L (40 mg/dL, "the higher, the better"), an LDL value of less than 2.6 mmol/L (100 mg/dL), and a triglycerides level of less than 1.7 mmol/L (150 mg/dL). Blood cholesterol in people with lifestyle, aging, or cardiovascular risk factors, such as diabetes mellitus, hypertension, family history of coronary artery disease, or angina, are evaluated at different levels.
=== Other issues === During an interview with the Associated Press in March 2023, Moore said that he understood why people continued to debate the issue of reparations to victims of slavery or their descendants and expressed support for efforts to address the modern impacts of institutional racism in the United States, including the racial wealth gap and disparities in food access, housing, and education. During the 2025 legislative session, he privately met with state legislators to raise concerns with a bill to study reparations in Maryland, reportedly showing lawmakers a draft executive order on reparations. Moore vetoed the reparations study bill in May 2025, saying that he felt that the issue had already been studied and that it was time "to focus on the work itself". He later announced that the state would provide over 400 communities impacted by racist policies with a "Just Communities" designation—which gives them a competitive advantage over other applicants for state grants and loans—and promised to work with lawmakers during the 2026 legislative session on a legislative package to address the racial wealth gap in Maryland. In December 2025, the Maryland General Assembly voted to override Moore's veto of the reparations study bill.
UPMC Community Osteopathic located in Harrisburg, Pennsylvania UPMC West Shore located in Mechanicsburg, Pennsylvania UPMC Somerset, a 111-bed, general acute care community hospital located in Somerset, Pennsylvania UPMC Susquehanna which comprises five hospitals, including its tertiary flagship UPMC Williamsport, operates the additional four community hospitals in north central Pennsylvania and one outpatient emergency center: UPMC Cole located in Coudersport, Pennsylvania. It has 25 beds and its labor and delivery unit is scheduled to close in April 2025. UPMC Lock Haven (outpatient emergency center) located in Lock Haven, Pennsylvania UPMC Muncy located in Muncy, Pennsylvania UPMC Wellsboro located in Wellsboro, Pennsylvania UPMC Williamsport Divine Providence Campus located in Williamsport, Pennsylvania UPMC Washington, a 244-bed hospital located in Washington, Pennsylvania UPMC Greene, a 23-bed hospital of the former Washington Health System located in Waynesburg, Pennsylvania UPMC Western Maryland, a 200-bed hospital located in Cumberland, Maryland
Sources: en.wikipedia.org
=== Nausea and vomiting === Tolerance to nausea occurs within 7–10 days, during which antiemetics (e.g. low dose haloperidol once at night) are very effective. Due to severe side effects such as tardive dyskinesia, haloperidol is now rarely used. A related drug, prochlorperazine is more often used, although it has similar risks. Stronger antiemetics such as ondansetron or tropisetron are sometimes used when nausea is severe or continuous and disturbing, despite their greater cost. A less expensive alternative is dopamine antagonists such as domperidone and metoclopramide. Domperidone does not cross the blood–brain barrier and produce adverse central antidopaminergic effects, but blocks opioid emetic action in the chemoreceptor trigger zone. This drug is not available in the U.S. Some antihistamines with anticholinergic properties (e.g. orphenadrine, diphenhydramine) may also be effective. The first-generation antihistamine hydroxyzine is commonly used, with the added advantages of not causing movement disorders, and also possessing analgesic-sparing properties. THC relieves nausea and vomiting; it also produces analgesia that may allow lower doses of opioids with reduced nausea and vomiting.
=== Cytochrome P450 inhibitors and inducers === The cytochrome P450 enzymes involved in the metabolism of selegiline have not been fully elucidated. CYP2D6 and CYP2C19 metabolizer phenotypes did not significantly affect the pharmacokinetics of selegiline, suggesting that these enzymes are minimally involved in its metabolism and that inhibitors and inducers of these enzymes would not importantly affect its pharmacokinetics. However, although most pharmacokinetic variables were unaffected, overall exposure to selegiline's metabolite levomethamphetamine was 46% higher in CYP2D6 poor metabolizers compared to extensive metabolizers and exposure to its metabolite desmethylselegiline was 68% higher in CYP2C19 poor metabolizers compared to extensive metabolizers. As with the cases of CYP2D6 and CYP2C19, the strong CYP3A4 and CYP3A5 inhibitor itraconazole has minimal impact on the pharmacokinetics of selegiline, suggesting lack of major involvement of this enzyme as well. On the other hand, the anticonvulsant carbamazepine, which is known to act as a strong inducer of CYP3A enzymes, has paradoxically been found to increase exposure to selegiline and its metabolites levomethamphetamine and levoamphetamine by approximately 2-fold (with selegiline used as the transdermal patch form). One enzyme thought to be majorly involved in the metabolism of selegiline based on in-vitro studies is CYP2B6. However, there are no clinical studies of different CYP2B6 metabolizer phenotypes or of CYP2B6 inhibitors or inducers on the pharmacokinetics of selegiline.
The two substrates of this enzyme are L-arogenic acid (shown as its conjugate base arogenate) and oxidised nicotinamide adenine dinucleotide (NAD+). Its products are L-tyrosine, reduced NADH, and carbon dioxide. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-CH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is L-arogenate:NAD+ oxidoreductase (decarboxylating). Other names in common use include arogenic dehydrogenase (ambiguous), cyclohexadienyl dehydrogenase, pretyrosine dehydrogenase (ambiguous), and L-arogenate:NAD+ oxidoreductase. This enzyme participates in phenylalanine, tyrosine and tryptophan biosynthesis and novobiocin biosynthesis.
==== Interdependence ==== The Huayan school taught the doctrine of the mutual containment and interpenetration of all phenomena (yuánróng, 圓融), as expressed in the metaphor of Indra's net. One thing contains all other existing things, and all existing things contain that one thing. This philosophy is based on the Avatamsaka Sutra and the writings of the patriarchs of Huayan. Thích Nhất Hạnh explains this concept as follows: "You cannot just be by yourself alone. You have to inter-be with every other thing." He uses the example of a sheet of paper that can only exist due to every other cause and condition (sunshine, rain, trees, people, the mind etc). According to Hanh "this sheet of paper is, because everything else is." Sogyal Rinpoche states all things, when seen and understood in their true relation, are not independent but interdependent with all other things. A tree, for example, cannot be isolated from anything else. It has no independent existence. According to Richard Gombrich, the East Asian interpretation of dependent origination as the idea that "all phenomena exert causal influence on each other" does not follow from the early Buddhist understanding of dependent origination. He further argues that this interpretation "would subvert the Buddha's teaching of karma." This is because "if we were heirs of other people's deeds, the whole moral edifice would collapse."
Those men that were stigmatic were non-ordained, including Saint Francis. Harrison argues that in many cases the stigmata was a consequence of the intense personal mystical ministries practiced by those excluded from the priesthood. Only in the twentieth century have cases of stigmatic priests appeared. One suggestion is that painful bruising syndrome may explain rare cases of non self-induced stigmata. Skeptical investigator Joe Nickell who investigated recent cases of stigmata such as Katya Rivas, as well as stigmatics throughout history, commented that the cases are indistinguishable from hoaxing. In 2002, a psychoanalytic study of stigmatic Therese Neumann suggested her stigmata resulted from post-traumatic stress symptoms expressed in unconscious self-mutilation through abnormal autosuggestibility. According to a study of the French theologian Joachim Bouflet, in the 21st century there were 200 stigmatics all over the world. Most of them reached the third age without having particular health problems. The oldest stigmatic was Marie-Julie Jahenny who died in 1941 at the age of 91. As of 1997, the stigmatics who had been declared saints by the Roman Catholic Church were only 7.
Sources: en.wikipedia.org
NAD+ is a coenzyme found in living cells and is the oxidized form of nicotinamide adenine dinucleotide. It accepts electrons in redox reactions and also serves as a substrate for certain signaling and repair enzymes.
NAD+ becomes NADH when it accepts a hydride ion during oxidation-reduction reactions. NADH then donates electrons to other molecules, after which the carrier can return to the NAD+ form.
No, nicotinamide is a smaller molecule and a component of NAD+. Cells can use nicotinamide to rebuild NAD+ through the salvage pathway.
NAD+ is the oxidized form and NADH is the reduced form of the same coenzyme. NAD+ accepts electrons during oxidation reactions, becoming NADH, which can donate electrons in other reactions. The ratio between them helps describe a cell's redox state.